Schering to buy Organon. Will there be any mid-sized pharmas left by 2009?
GSK’s CEO Garnier with some comments on sales/marketing costs – the 4th paragraph is quite interesting, about sales force testing/certification.
Speaking of GSK, Tykerb gets approval for breast cancer.
Popping sleeping pills? You’re not alone…